Vaccitech to Present at the William Blair Biotech Focus Conference 2022

OXFORD, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ:VACC ), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced that the Company's Chief Executive Officer, Bill Enright, will participate in a fireside chat at the William Blair Biotech Focus Conference 2022 in New York, July 11 to 12. Mr. Enright will also host one on one meetings with investors at the conference. The webcast of the event will be available starting at 9 a.m. EDT on July 11 and can be accessed through the Events  section of the ... Full story available on Benzinga.com